Japan’s Finance Ministry declines to comment on the Yen's sudden spike
When asked about the sudden spike in the Japanese Yen (JPY), Japan’s Finance Ministry declined to comment, per Reuters.
In the last hours, JPY has experienced unexpected bouts of strong buying, leaving USD/JPY volatile between 161.00 and 162.00 levels.
Traders stay to the prospect of intervention from Japan to prop up its stubbornly weak currency from 40-year lows against the US Dollar (USD), while weighing a possible new approach to Yen-buying from Japanese officials.
Additionally, Japan's top currency diplomat Atsushi Mimura has stated that he won't comment on forex levels.
Market reaction
At the press time, USD/JPY is losing 0.82% on the day at 161.22.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The "Outlier" Investment Art in the New Era of Berky

Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India
Chevron is focusing on Argentina and the Mediterranean region, seeking global growth in liquefied natural gas, and plans to reach an agreement with India.

Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge
The upward pressure on energy prices caused by the unresolved Middle East war is mounting. New risks are also approaching, which may keep inflation above the Bank of England’s 2% target for most of next year.

AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales
Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.

